Search research articles
Contact Us
Filters
Showing results (101-110 of 149) with videos related to
Page
of 15
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 4, 2013
microRNA expression profiles identify subtypes of mantle cell lymphoma with different clinicobiological characteristics
Alba Navarro, Guillem Clot, Miriam Prieto, et al.
British Journal of Haematology
|
February 28, 2020
Genomic evolution of ibrutinib-resistant clones in Waldenström macroglobulinaemia
Cristina Jiménez, Gloria G Chan, Lian Xu, et al.
Cancer Research
|
March 7, 2014
Auranofin induces lethal oxidative and endoplasmic reticulum stress and exerts potent preclinical activity against chronic lymphocytic leukemia
Warren Fiskus, Nakhle Saba, Min Shen, et al.
Cancer Research
|
October 11, 2017
MALT1 Inhibition Is Efficacious in Both Naïve and Ibrutinib-Resistant Chronic Lymphocytic Leukemia
Nakhle S Saba, Deanna H Wong, Georges Tanios, et al.
Leukemia
|
June 24, 2025
Resistance to targeted therapies in chronic lymphocytic leukemia: Current status and perspectives for clinical and diagnostic practice
Piers Blombery, Thomas Chatzikonstantinou, Marina Gerousi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 19, 2015
Interactions between Ibrutinib and Anti-CD20 Antibodies: Competing Effects on the Outcome of Combination Therapy
Martin Skarzynski, Carsten U Niemann, Yuh Shan Lee, et al.
Blood Advances
|
March 31, 2022
The immune microenvironment shapes transcriptional and genetic heterogeneity in chronic lymphocytic leukemia
Clare Sun, Yun-Ching Chen, Aina Martinez Zurita, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
April 19, 2015
Nomenclature of Toso, Fas apoptosis inhibitory molecule 3, and IgM FcR
Hiromi Kubagawa, Michael C Carroll, Chaim O Jacob, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 25, 2023
CD49d Expression Identifies a Biologically Distinct Subtype of Chronic Lymphocytic Leukemia with Inferior Progression-Free Survival on BTK Inhibitor Therapy
Anfal Alsadhan, Jonathan Chen, Erika M Gaglione, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 23, 2021
SOX11 Inhibitors Are Cytotoxic in Mantle Cell Lymphoma
Shashidhar S Jatiani, Stephanie Christie, Violetta V Leshchenko, et al.
Page
of 15
Search research articles
Search
Showing results (101-110 of 149) with videos related to
Sort By:
Page
of 15
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 4, 2013
microRNA expression profiles identify subtypes of mantle cell lymphoma with different clinicobiological characteristics
Alba Navarro, Guillem Clot, Miriam Prieto, et al.
British Journal of Haematology
|
February 28, 2020
Genomic evolution of ibrutinib-resistant clones in Waldenström macroglobulinaemia
Cristina Jiménez, Gloria G Chan, Lian Xu, et al.
Cancer Research
|
March 7, 2014
Auranofin induces lethal oxidative and endoplasmic reticulum stress and exerts potent preclinical activity against chronic lymphocytic leukemia
Warren Fiskus, Nakhle Saba, Min Shen, et al.
Cancer Research
|
October 11, 2017
MALT1 Inhibition Is Efficacious in Both Naïve and Ibrutinib-Resistant Chronic Lymphocytic Leukemia
Nakhle S Saba, Deanna H Wong, Georges Tanios, et al.
Leukemia
|
June 24, 2025
Resistance to targeted therapies in chronic lymphocytic leukemia: Current status and perspectives for clinical and diagnostic practice
Piers Blombery, Thomas Chatzikonstantinou, Marina Gerousi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 19, 2015
Interactions between Ibrutinib and Anti-CD20 Antibodies: Competing Effects on the Outcome of Combination Therapy
Martin Skarzynski, Carsten U Niemann, Yuh Shan Lee, et al.
Blood Advances
|
March 31, 2022
The immune microenvironment shapes transcriptional and genetic heterogeneity in chronic lymphocytic leukemia
Clare Sun, Yun-Ching Chen, Aina Martinez Zurita, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
April 19, 2015
Nomenclature of Toso, Fas apoptosis inhibitory molecule 3, and IgM FcR
Hiromi Kubagawa, Michael C Carroll, Chaim O Jacob, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 25, 2023
CD49d Expression Identifies a Biologically Distinct Subtype of Chronic Lymphocytic Leukemia with Inferior Progression-Free Survival on BTK Inhibitor Therapy
Anfal Alsadhan, Jonathan Chen, Erika M Gaglione, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 23, 2021
SOX11 Inhibitors Are Cytotoxic in Mantle Cell Lymphoma
Shashidhar S Jatiani, Stephanie Christie, Violetta V Leshchenko, et al.
Page
of 15